AI for Serialization and DSCSA Exception Handling
A controlled, human-in-the-loop operating model for pharma traceability exceptions, EPCIS data quality, deterministic automation, and AI-assisted exception management.
What this white paper covers
- Why DSCSA exception handling is becoming operationally unsustainable
- What breaks in serialization and EPCIS data exchange
- Where deterministic automation, RPA, and AI assistance fit
- How readiness and risk should determine automation authority
- How SCW helps build scalable exception operations
Executive Summary
The U.S. pharmaceutical industry has entered a new phase of Drug Supply Chain Security Act (DSCSA) compliance. For many organizations, the challenge is no longer implementing package-level traceability, but operating it efficiently at scale.
As electronic data exchange becomes part of daily operations, serialization and supply chain teams must manage EPCIS data discrepancies, partner interoperability issues, verification requests, and product-data mismatches. Resolving these exceptions quickly and consistently is essential to maintaining product flow while meeting regulatory requirements.
Automation and artificial intelligence can improve these operations, but they should not be applied indiscriminately. The objective is to resolve exceptions faster, more consistently, and with less manual effort while maintaining compliance and appropriate human oversight.
SCW helps pharma companies modernize serialization, EPCIS, and exception operations through Track & Trace, Process Excellence & RPA, RPA, and Digital Supply Chain services.
Why DSCSA Exception Management Is Becoming Operationally Unsustainable
The operational burden of DSCSA becomes most visible when physical product movement and transaction data are not synchronized. Exceptions can originate from timing gaps, inconsistencies in product or master data, discrepancies within serialized hierarchies, missing or incorrectly sequenced events, or differences in how trading-partner systems generate, transmit, receive, and validate EPCIS information.
Technical connectivity alone does not ensure effective interoperability. FDA’s DSCSA Pilot Project Program identified variations from standards and guidelines during industry data exchange, including formatting issues, sequencing errors, incorrect syntax, and missing data fields.
HDA exception handling guidance notes that transaction-data issues generally need to be handled and resolved before affected products can be sold downstream, depending on the nature and timing of the exception. GS1 US DSCSA implementation guidance emphasizes the need to monitor data-exchange failures and resolve misalignment between physical product and serialized transaction data.
Manual effort increases
Teams must retrieve records, compare data, gather evidence, contact partners, and document outcomes for a growing volume of cases.
Product flow can slow
Transaction-data issues may delay downstream saleability and create operational friction across partners.
Governance becomes critical
Organizations need consistent triage, ownership, escalation, documentation, and continuous improvement routines.
SCW supports DSCSA exception workflow design, EPCIS data quality improvement, partner onboarding, and traceability operations. Explore Track & Trace services or schedule a consultation.
What Breaks in Serialization and EPCIS Data
DSCSA exceptions are often described operationally as Product, No Data, Data, No Product, or Data Issue scenarios. These categories are useful for managing the resulting case, but underlying causes can originate at several layers of the serialization and data-exchange process.
A practical view of the failure landscape is provided in SCW’s Top 25 EPCIS Data Errors That Break Interoperability, which translates recurring interoperability challenges into five operational groups.
| Issue family | Examples | Typical operational consequence |
|---|---|---|
| Identifier and master-data defects | Invalid or inconsistent GTIN, GLN, SSCC, lot, expiration date, or product and location data | File rejection, inability to match product and transaction data, or trading-partner processing failures |
| Event-structure defects | Missing or incorrect business step, disposition, readPoint, event type, or aggregation relationship | EPCIS data may be technically received but fail downstream validation or business logic |
| Transport and version defects | AS2 transmission failures, missing MDNs, certificate issues, EPCIS version incompatibility, or file-processing failures | Delayed or failed data exchange, duplicate attempts, and unresolved receipt status |
| Choreography and timing defects | Out-of-sequence events, late transmission, missing expected events, or incorrect shipment and receipt flows | Physical product and electronic transaction history become misaligned |
| Verification and packaging defects | Unreadable 2D barcodes, incomplete human-readable information, unexpected serialization status, or label discrepancies | Verification failure, product hold, investigation, or escalation into higher-risk workflows |
The standards layer adds another dimension. GS1 EPCIS and CBV standards provide standardized capture and query interfaces for visibility-event data and the business vocabulary needed to interpret events consistently.
From Deterministic Automation to AI-Assisted Exception Management
The strongest application of AI in DSCSA exception management is not autonomous compliance decision-making. It is selective use of AI within a controlled operating model that combines reliable data, operational context, deterministic automation, and human oversight.
Practical progression
Reliable Data → Operational Context → Deterministic Automation → AI-Assisted Intelligence → Governed Action
Known conditions should be evaluated deterministically before probabilistic models are invoked. AI should then operate on the resulting case context rather than attempting to infer facts that can be established directly through system queries, validation rules, or structured comparisons.
| Layer | Role in DSCSA exception management | Operational impact |
|---|---|---|
| Deterministic validation | Schema and CBV validation, identifier checks, partner/version validation, sequence logic, and policy gates | Establishes trusted case facts and resolves known conditions before AI is invoked |
| Classification and routing | Predict exception family, subtype, likely workflow, and appropriate queue from structured case data | Accelerates triage and promotes consistent case handling |
| Prioritization | Rank cases using product impact, aging, partner history, SLA exposure, and operational urgency | Directs resources toward the most consequential exceptions |
| Investigation and root-cause support | Analyze EPCIS events, case history, partner behavior, hierarchy, transmission status, and prior resolutions | Reduces investigative effort and supports faster root-cause identification |
| Language and knowledge assistance | Retrieve SOPs, partner playbooks, prior cases, evidence, and draft case summaries or communications | Reduces search and documentation effort while keeping outputs reviewable |
| Governed action | Recommend next actions and execute only authorized actions under defined business and compliance controls | Preserves accountability and limits automation authority |
This principle is already reflected in practical serialization automation. SCW’s RPA x AI materials for EMVS alert management show how RPA can extract alert data, apply predefined rules, perform first-level assessment, interrogate serialization systems, compare batch and serial information, validate product and reporting status, capture evidence, document findings, and escalate cases requiring further investigation.
For organizations looking to reduce repetitive exception-handling work, SCW supports Process Excellence & RPA, RPA implementation, and Digital Supply Chain transformation.
Determining the Right Level of Automation: Readiness × Risk
The appropriate level of automation for a DSCSA exception should not be determined by AI confidence alone. Two separate considerations are required: whether the process is ready to be automated reliably and how consequential an incorrect action would be.
Data readiness
Are required EPCIS, master, shipment, partner, and case data complete, reliable, and accessible?
Process readiness
Are investigation and resolution steps standardized and repeatable?
Integration readiness
Can required systems and evidence sources be accessed reliably and securely?
Knowledge readiness
Are SOPs, partner rules, prior resolutions, and escalation criteria documented?
Validation readiness
Can expected outputs be objectively evaluated and monitored?
Risk authority
Would an incorrect action affect operations, quality, compliance, or patient safety?
| Readiness / Risk | Appropriate operating model | Representative DSCSA activities |
|---|---|---|
| High readiness / lower risk | Automate within validated rules and defined controls | Case intake, EPCIS parsing, deduplication, validation, receipt checks, evidence retrieval, routing, reminders, and status sync |
| High readiness / moderate risk | Automate and AI assist, with defined human review where outputs affect resolution | Exception classification, prioritization, evidence assembly, likely root-cause support, recommended workflow, and draft partner responses |
| Lower readiness / lower to moderate risk | Assist before automating | Variable partner processes, inconsistent EPCIS or master data, limited case history, and non-standard investigation paths |
| Any readiness / higher risk | Human-controlled decision, with automation and AI limited to evidence gathering and recommendation | Product quarantine or release decisions, suspect or illegitimate product determinations, regulatory notifications, final corrections to regulated records, and compliance-sensitive actions |
NIST’s AI Risk Management Framework emphasizes context-specific measurement, governance, and ongoing evaluation of AI systems. The NIST Generative AI Profile reinforces the importance of defined human-AI roles, oversight, evaluation, and risk-proportionate controls.
Future-State Operating Model: From Exception Detection to Resolution
A modern DSCSA exception-management model should connect detection, investigation, resolution, and continuous improvement within a single governed workflow.
Detect & Validate
Rules validate known conditions, retrieve records, and eliminate false or duplicate cases.
Classify & Prioritize
AI can support classification, prioritization, and routing using case context and historical patterns.
Investigate
Automation gathers evidence and performs repeatable checks while AI supports synthesis and likely root-cause identification.
Recommend & Resolve
AI can recommend next actions and draft communications while humans approve or execute higher-risk decisions.
Document & Close
Automation assembles the case record and verifies required documentation.
Learn & Improve
Analytics and AI identify recurring patterns and opportunities for prevention or process improvement.
Exception management can evolve from a primarily reactive function into a source of operational insight and continuous improvement, with the longer-term objective of reducing both the frequency and operational impact of recurring exceptions.
Maturity path for DSCSA exception management
The Path Forward: Building Scalable DSCSA Exception Operations with SCW
DSCSA exception management is becoming a sustained operational capability rather than a temporary implementation challenge. As serialized data volumes, trading-partner interactions, and interoperability requirements increase, organizations need operating models that can manage exceptions efficiently while maintaining compliance, traceability, and appropriate control.
The path forward does not require replacing established serialization platforms or pursuing end-to-end autonomy. It starts with strengthening the operational foundation: reliable EPCIS and master data, standardized exception workflows, clear ownership and decision rights, effective trading-partner onboarding and governance, and integrated access to the systems and evidence required for investigation.
Map the current workflow
Understand exception families, volumes, aging, handoffs, systems, evidence requirements, partner dependencies, and pain points.
Assess readiness and risk
Determine where data, processes, integrations, and governance are mature enough for automation, and where human authority must remain.
Prioritize the right opportunities
Apply deterministic automation first to stable, repeatable activities and introduce AI where decision support creates measurable value.
Pilot, validate, and scale
Measure time to triage, resolution, SLA attainment, manual touches, queue aging, re-open rates, partner turnaround, AI performance, overrides, and record completeness.
Strengthen governance
Define controls for confidence thresholds, escalation logic, approvals, documentation, auditability, and continuous monitoring.
Reduce recurrence
Use exception intelligence to improve partner performance, master data, business rules, workflow design, and prevention routines.
Related SCW services and resources: Track & Trace, Process Excellence & RPA, RPA, Digital Supply Chain, and EPCIS migration support.
Ready to build scalable, controlled DSCSA exception operations?
SCW helps pharma companies strengthen EPCIS data quality, modernize exception workflows, apply RPA where work is deterministic, introduce AI-assisted decision support where appropriate, and preserve human accountability where consequences matter.
References
- U.S. Food and Drug Administration. Enhanced Drug Distribution Security at the Package Level Under the Drug Supply Chain Security Act: Guidance for Industry.
- U.S. Food and Drug Administration. DSCSA Pilot Project Program.
- Healthcare Distribution Alliance. Exceptions Handling Guidelines for the DSCSA.
- GS1 US. DSCSA Implementation Guidelines.
- Partnership for DSCSA Governance, HDA, and GS1 US. Exception Handling Workshop Report.
- Supply Chain Wizard. Top 25 EPCIS Data Errors That Break Interoperability.
- GS1. EPCIS Standard Archive and Core Business Vocabulary.
- Supply Chain Wizard. RPA x AI: EMVS Alert Management RPA Solution Suite.
- Partnership for DSCSA Governance. Foundational Blueprint for 2023 Interoperability.
- Open Credentialing Initiative. DSCSA Interoperability Specification: Credential Schema.
- NIST. Artificial Intelligence Risk Management Framework AI RMF 1.0.
- NIST. Artificial Intelligence Risk Management Framework: Generative Artificial Intelligence Profile.
